Ocular Disease News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ocular disease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ocular Disease Today - Breaking & Trending Today

Study Finds AA Associated With Connective Tissue, Ocular Diseases and Vitamin D Deficiency

Meta-analysis results identify high and low associations of various comorbidities like vitamin D deficiencies, ocular diseases, among others in patients with alopecia areata (AA), to promptly manage and improve treatment outcomes. ....

Image Credit , Preferred Reporting Items , Systematic Reviews , Alopecia Areata , Vitamind Deficiency , Systemic Lupus Erythematous , Hashimoto Thyroiditis , Thyroid Disease , Ocular Disease , Metabolic Syndrome , Colorectal Cancer , Irritable Bowl Syndrome , Connective Tissue , Autoimmune Diseases ,

AI-Led Eye 'Aging Clock' Unveils New Therapeutics For Eye Disorders

Artificial intelligence-powered eye-aging clock facilitates the tracking of ocular aging, revealing new potential target therapies for a range of eye disorders. ....

Vinit Mahajan , Julian Wolf , Eye Aging Clock , Ocular Disease , Artificial Intelligence , Eye Disorders , Herapies For Ocular Diseases ,

Shape, Otsuka ink $1.5B gene therapy alliance targeting ocular diseases

In its second big pharma deal to date, Shape Therapeutics Inc. drew Otsuka Pharmaceutical Co. Ltd. to the table in a potential $1.5 billion-plus collaboration initially aimed at developing gene therapies for ocular diseases. The multitarget agreement, which includes options for additional targets and tissue types, will combine Shape’s AI-driven adeno-associated virus (AAV) platform and Otsuka’s expertise in ophthalmology to develop intravitreally delivered AAV therapies. ....

Shape Therapeutics Inc , Otsuka Pharmaceutical Co , Shape Therapeutics , Otsuka Pharmaceutical , Shape Therapeutics Inc , Otsuka Pharmaceutical Co Ltd , Artificial Intelligence , Generative Ai , Ocular Disease ,